DBV Technologies S.A.

DBVTNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

296.1M

on 2026-07-16, from 96.4M on 2024-05-07 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$150.0M

Citizens JMP Securities, agreement of 2025-09-05. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-07-16 is not read yet.

Cash

4.1 quarters

$174.9M on 2026-06-30 ÷ $42.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 5 of its filings are not read yet.